You could have joined this comprehensive summit and united with biopharma and academic experts in characterization techniques and analytical technologies.

In the ever-evolving exosome field, the past year has witnessed remarkable progress, making the growing need for standardization of techniques and technologies increase. Meeting regulatory needs presents a challenge, highlighting the growing importance of developing resilient techniques. These techniques serve as the cornerstone for exosome therapeutics, complementing advancements in drug delivery applications. 

The Exosome Characterization & Analytical Development Summit offered a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes. 

Expert speakers from Rion Therapeutics, Harvard Medical School, Astellas, AbbVie, and many others prepared exclusive presentations based on recent case studies and data, informing attendees about what is to come in the exosome field. You could have networked to ask your burning questions, aid your decision-making, and ultimately progress your pipelines.